These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
100 related items for PubMed ID: 1721400
1. Neuropathologic findings in liver transplantation: a comparative study of cyclosporine and FK 506. Lopez OL, Martinez AJ, Torre-Cisneros J. Transplant Proc; 1991 Dec; 23(6):3181-2. PubMed ID: 1721400 [No Abstract] [Full Text] [Related]
2. Comparison of FK 506- and cyclosporine-based immunosuppression: FK 506 therapy significantly reduces the incidence of acute, steroid-resistant, refractory, and chronic rejection whilst possessing a comparable safety profile. European FK 506 Multicenter Liver Study Group. Bismuth H. Transplant Proc; 1995 Feb; 27(1):45-9. PubMed ID: 7533415 [No Abstract] [Full Text] [Related]
3. [Comparison between tacrolimus (FK 506) and cyclosporin in immunosuppressive therapy after liver transplantation]. Arnold JC, Theilmann L. Z Gastroenterol; 1995 Oct; 33(10):624-5. PubMed ID: 7502559 [No Abstract] [Full Text] [Related]
4. Tacrolimus (FK 506) therapy is associated with a significant reduction in immunosuppressive treatment failures following primary liver transplantation. Bechstein WO, Neuhaus P, McMaster P, Calne R, Pichlmayr R, Otto G, Williams R, Ericzon BG, Bismuth H. Transplant Proc; 1996 Apr; 28(2):1008-10. PubMed ID: 8623211 [No Abstract] [Full Text] [Related]
10. Clinical use of FK 506 in liver transplantation. Klintmalm GB. Transplant Proc; 1996 Apr; 28(2):974-6. PubMed ID: 8623484 [Abstract] [Full Text] [Related]
11. Immunosuppression conversion for relief of side effects. Guy S, Mor E, Fisher A, Schwartz M, Sheiner P, Emre S, Miller C. Transplant Proc; 1994 Dec; 26(6):3235-6. PubMed ID: 7527956 [No Abstract] [Full Text] [Related]
12. Conversion from tacrolimus to cyclosporine--a based immunosuppression following liver transplantation. Doria C, Jain AK, Scott VL, Gruttadauria S, Marino IR, Doyle HR, Fung JJ. Exp Clin Transplant; 2003 Jun; 1(1):48-55. PubMed ID: 15859907 [Abstract] [Full Text] [Related]
16. A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine. Fung J, Abu-Elmagd K, Jain A, Gordon R, Tzakis A, Todo S, Takaya S, Alessiani M, Demetris A, Bronster O. Transplant Proc; 1991 Dec; 23(6):2977-83. PubMed ID: 1721333 [No Abstract] [Full Text] [Related]
17. Neurologic symptoms improve in patients with Wilson's disease despite immunosuppression. Schumacher G, Mueller AR, Platz KP, Neuhaus R, Bechstein WO, Becker M, Luck W, Neuhaus P. Transplant Proc; 1996 Dec; 28(6):3099-100. PubMed ID: 8962200 [No Abstract] [Full Text] [Related]
18. Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence. Vivarelli M, Cucchetti A, La Barba G, Ravaioli M, Del Gaudio M, Lauro A, Grazi GL, Pinna AD. Ann Surg; 2008 Nov; 248(5):857-62. PubMed ID: 18948815 [Abstract] [Full Text] [Related]
19. Causes of death following liver transplantation in FK 506- and cyclosporine-treated patients. Platz KP, Mueller AR, Bechstein WO, Blumhardt G, Neuhaus P. Transplant Proc; 1994 Dec; 26(6):3133-4. PubMed ID: 7527952 [No Abstract] [Full Text] [Related]
20. FK 506 versus cyclosporine in pediatric liver transplantation. Tzakis AG, Reyes J, Todo S, Green M, Ohya T, Jain A, Abu-Elmagd K, Alessiani M, Fung JJ, Starzl TE. Transplant Proc; 1991 Dec; 23(6):3010-5. PubMed ID: 1721343 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]